X0609 4 2026-06-22 0 0001743881 BridgeBio Pharma, Inc. BBIO 0001621788 Satvat Ali J. false C/O KOHLBERG KRAVIS ROBERTS & CO. L.P. 2800 SAND HILL ROAD MENLO PARK CA 94025 1 0 0 0 0 Common Stock 2026-06-22 4 A 0 3990 0 A 169983 D Stock Option (Right to Buy) 68.92 2026-06-22 4 A 0 5277 0 A 2036-06-21 Common Stock 5277 5277 D Grant of restricted stock units ("RSUs") under the Issuer's 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan. The RSUs vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. The shares underlying the stock option vest in full on June 22, 2027, subject to the Reporting Person's continued service on the Issuer's board of directors through the vesting date. Exhibit 24 - Power of Attorney /s/ Will Solis, Attorney-in-Fact 2026-06-24